1 Sarah N. Westcot (State Bar No. 264916) BURSOR & FISHER, P.A. 2 701 Brickell Ave., Suite 1420 Miami, FL 33131-2800 3 Telephone: (305) 330-5512 4 Facsimile: (305) 676-9006 E-Mail: [email protected] 5 L.Timothy Fisher (State Bar No. 191626) 6 BURSOR & FISHER, P.A. 1990 North California Blvd., Suite 940 7 Walnut Creek, CA 94596 8 Telephone: (925) 300-4455 Facsimile: (925) 407-2700 9 E-Mail: [email protected] 10 Attorneys for Plaintiffs 11 ( additional counsel on signature page) 12 UNITED STATES DISTRICT COURT 13 FOR THE NORTHERN DISTRICT OF CALIFORNIA 14 JORDAN NELSON and REGINA PERALTA, ) Case No. 4:23-cv-04875-HSG individually and on behalf of all others similarly ) 15 situated, ) STIPULATION AND ORDER 16 Plaintiffs, ) ) TO SUBSTITUTE PARTY NAME, AMEND CAPTION, AND vs. ) 17 ) TO ENLARGE TIME FOR KENVUE, INC., MCNEIL CONSUMER ) RESPONSIVE PROCEEDINGS 18 HEALTHCARE, JOHNSON & JOHNSON ) PENDING MDL 19 CONSUMER, INC., CVS PHARMACY, INC., ) ) D JuE dT gE e:R MIN HA oT nI .O HN a ywood S. Gilliam, Jr. HALEON US CAPITAL LLC, GSK PLC, ) Courtroom: 2 – 4th Floor 20 ALBERTSONS COMPANIES, INC., TARGET ) CORPORATION, WALMART INC., and ) 21 PERRIGO COMPANY PLC, ) ) 22 Defendants. ) 23 24 25 26 27 1 WHEREAS, Plaintiffs Jordan Nelson and Regina Peralta (“Plaintiffs”) filed the above- 2 captioned action against Defendants Kenvue, Inc., McNeil Consumer Healthcare, Johnson & Johnson 3 Consumer, Inc., CVS Pharmacy, Inc., Haleon US Capital LLC, GSK Plc, Albertsons Companies, Inc., 4 Target Corporation, Walmart Inc., and Perrigo Company Plc (“Defendants”) on September 22, 2023 5 (the “Complaint”), 6 WHEREAS, Haleon US Capital LLC and GSK plc were incorrectly named as defendants in 7 this action; 8 WHEREAS, GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (“Haleon”) is the 9 proper defendant regarding certain products alleged in the Complaint; 10 WHEREAS, Kenvue, Inc. and McNeil Consumer Healthcare were incorrectly named as 11 defendants in this action; 12 WHEREAS, Johnson & Johnson Consumer Inc. (“JJCI”) is the proper defendant regarding 13 certain products alleged in the Complaint; 14 WHEREAS, a petition has been filed before the Judicial Panel on Multidistrict Litigation (the 15 “JPML”) to consolidate certain civil actions now pending inside and outside of this District into a 16 single multidistrict litigation (the “MDL Petition”); 17 WHEREAS, the MDL Petition has identified at least thirteen actions it seeks to consolidate in 18 MDL No. 3089, and at least sixty additional actions are pending across the country that may also be 19 deemed related actions (together with any other actions that are the subject of the MDL Petition, the 20 “Related Actions”); 21 WHEREAS, Plaintiffs have filed a Notice of Related Actions in the MDL proceeding 22 identifying this action as related to those identified in the MDL Petition, see In re: Oral Phenylephrine 23 Marketing and Sales Practices Litigation, MDL No. 3089, ECF No. 51; 24 WHEREAS, the MDL Petition has been docketed before the JPML as In re: Oral 25 Phenylephrine Marketing and Sales Practices Litigation, MDL No. 3089, and responses to the MDL 26 Petition are due on or before October 25, 2023, with a reply due on or before November 1, 2023; 27 1 1 WHEREAS, oral argument on the MDL Petition is scheduled to take place on November 30, 2 2023 before the JPML panel, see In re: Oral Phenylephrine Marketing and Sales Practices Litigation, 3 MDL No. 3089, ECF No. 166; 4 WHEREAS, this Court has the inherent power to grant a stay, especially in circumstances 5 such as here, where doing so would promote judicial economy and avoid prejudice to the parties, see, 6 e.g., Landis v. North Am. Co.,

(1936); Gutierrez v. Samsung Elecs. Am., Inc. 2022

, at *1 (N.D. Cal. Oct. 27, 2022) (granting stipulation to stay pending JPML decision); 8 L.A.T. v. Meta Platforms, Inc.,

, at *1 (N.D. Cal. Sept. 15, 2022) (same); Butler v. 9 McKesson Corp.,

, at *2 (Aug. 12, 2013 N.D. Cal.) (granting motion to stay pending 10 contested motion to transfer to MDL); 11 WHEREAS, absent relief from currently pending deadlines, the Court and the parties would 12 face responsive pleading deadlines and, in light of the possibility that there will be an MDL 13 consolidating the Related Actions for the purpose of pretrial proceedings, an extension of those 14 deadlines is prudent to avoid duplication of pretrial efforts by the parties, any waste of judicial 15 resources, and the risk of conflicting rulings; 16 WHEREAS the parties have met and conferred and agree that responsive pleading deadlines 17 should be stayed pending resolution of the MDL Petition; 18 THEREFORE, THE PARTIES HEREBY STIPULATE, AGREE AND 19 RESPECTFULLY REQUEST THAT: 20 1. Defendants “Haleon US Capital LLC” and “GSK plc” are dismissed without prejudice and will 21 be replaced by defendant “GlaxoSmithKline Consumer Healthcare Holdings (US) LLC” and 22 the caption in this action shall be amended to reflect that substitution; 23 2. Defendants “Kenvue, Inc.” and “McNeil Consumer Healthcare” are dismissed without 24 prejudice and the caption in this action shall be amended to reflect that dismissal; 25 26 27 2 1 3. This Court stays any served Defendant’s deadline to answer, move, or otherwise plead in 2 response to the Complaint, or any subsequently filed amended complaint until further order of 3 this Court or any Court to which the JPML assigns the Related Actions; 4 4. Because this case has been submitted to the JPML as a related case, the Court will receive 5 notice from the JPML if an MDL is formed. If the JPML denies the motion to form an MDL, 6 the Parties will meet and confer within 14 days of the JPML’s ruling and prepare a joint status 7 report for the Court; 8 5. The parties’ entry into this stipulation does not constitute a waiver of any jurisdictional 9 defenses that may be available under Rule 12 of the Federal Rules of Civil Procedure, including 10 personal jurisdiction, a waiver of any defenses under Rule 8 of the Federal Rules of Civil 11 Procedure, or a waiver of any other statutory or common law defenses that may be available 12 to any Defendant in this action, the Related Actions, or both. Defendants expressly reserve 13 their rights to raise any such defenses in response to any operative or amended complaint that 14 may be filed relating to this action. 15 16 17 18 19 20 21 22 23 24 25 26 27 3 1 Dated: October 18, 2023 Respectfully submitted, 2 /s/ Sarah N. Westcot Sarah N. Westcot (State Bar No. 264916) 3 BURSOR & FISHER, P.A. 4 701 Brickell Ave., Suite 1420 Miami, FL 33131-2800 5 Telephone: (305) 330-5512 Facsimile: (305) 676-9006 6 E-Mail: [email protected] 7 L.Timothy Fisher (State Bar No. 191626) 8 BURSOR & FISHER, P.A. 1990 North California Blvd., Suite 940 9 Walnut Creek, CA 94596 Telephone: (925) 300-4455 10 Facsimile: (925) 407-2700 11 E-Mail: [email protected] 12 Attorneys for Plaintiffs 13 14 Dated: October 18, 2023 Respectfully submitted, 15 /s/ Amy J. Laurendeau /s/ Robyn E. Bladow Amy J. Laurendeau (SBN 198321) Robyn E. Bladow (SBN 205189) 16 O’MELVENY & MYERS LLP KIRKLAND & ELLIS LLP 610 Newport Center Drive, 17th Fl. 555 S. Flower Street 17 Newport Beach, CA 92660 Los Angeles, CA 90071 Telephone: (949) 823-6900 Tel: (213) 680-8400 18 Facsimile: (949) 823-6994 [email protected] [email protected] 19 Attorneys for Defendant GlaxoSmithKline Hannah Y. Chanoine (SBN 4380622) Consumer Healthcare Holdings (US), LLC 20 (Pro Hac Forthcoming) O’MELVENY & MYERS LLP /s/ Robert J. Herrington 21 Times Square Tower GREENBERG TRAURIG, LLP 7 Times Square Robert J. Herrington (SBN CA 234417) 22 New York, NY 10036 [email protected] Tel: (212) 326-2000 1840 Century Park East, Suite 1900 23 Facsimile: (212) 326-2061 Los Angeles, CA 90067-2121 Tel.: 310.586.7700 24 Attorneys for Defendant Johnson & Johnson Fax: 310.586.7800 Consumer Inc. 25 Counsel for CVS Pharmacy, Inc. and Target Corporation 26 27 4 1 /s/ Livia M. Kiser /s/ Amanda L Groves Livia M. Kiser (SBN 285411) Amanda L Groves 2 Michael B. Shortnacy (SBN 277035) Winston & Strawn LLP Michael L. Resch (SBN 202909) 333 S. Grand Avenue 3 KING & SPALDING, LLP Los Angeles, CA 90071 633 W Sth St Suite 1600 (213) 615-1851 4 Los Angeles, CA 90071 Email: [email protected] Tel: (213) 443-4355 5 Fax: (213) 443-4310 Jeff Wilkerson Email: [email protected] Winston & Strawn LLP 6 Email: [email protected] 300 S. Tryon Street, 16" Floor Email: [email protected] Charlotte, NC 28202 7 (704) 350-7714 Attorneys for Walmart Inc. Email: [email protected] 8 Attorneys for Albertsons Companies, Inc. 9 10 M SIGNATURE ATTESTATION 12 Pursuant to Local Rule 5-1()(3) regarding signatures, I, Sarah N. Westcot, attest that 13 concurrence in the filing of this document has been obtained by the other signatory to this document. 14 15 By:___/s/ Sarah N. Westcot 16 | IP IS SO ORDERED. 18 19 || Dated: 10/19/2023 7 Uaepreed 4 hh. □ HAYWOOD S. GILLIAM, JR. 20 United States District Judge 21 22 23 24 25 26 27 9g || — STIPULATION AND ORDER TO SUBSTITUTE PARTY NAME, AMEND CAPTION, AND TO ENLARGE TIME FOR RESPONSIVE PROCEEDINGS PENDING MDL DETERMINATION